Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposome vs hydrochloride bupivacaine for quadratus lumborum block in laparoscopic hysterectomy
ChiCTR2500104281Phase 4Recruiting
- Sponsor
- Chengdu Fifth People's Hospital
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine in Fibromyoma (LM) (2 arms), sponsored by Chengdu Fifth People's Hospital. Primary endpoint: QoR-40 score 24 hours after surgery. Started Jun 2025; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on ChiCTR2500104281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104281.